Masaru Matsuda, the See Remarks of $ARQT, sold 19,379 shares of the company on 02-02-2026 for an estimated $489,125. We received data on the trade from a recent SEC filing. This was a sale of approximately 14.5% of their shares of this class of stock. Following this trade, they now own 114,717 shares of this class of $ARQT stock.
$ARQT Insider Trading Activity
$ARQT insiders have traded $ARQT stock on the open market 51 times in the past 6 months. Of those trades, 0 have been purchases and 51 have been sales.
Here’s a breakdown of recent trading of $ARQT stock by insiders over the last 6 months:
- TODD WATANABE (See Remarks) has made 0 purchases and 11 sales selling 176,509 shares for an estimated $4,371,822.
- MASARU MATSUDA (See Remarks) has made 0 purchases and 10 sales selling 88,183 shares for an estimated $1,911,390.
- PATRICK BURNETT (See Remarks) has made 0 purchases and 13 sales selling 60,927 shares for an estimated $1,494,864.
- HOWARD G. WELGUS has made 0 purchases and 7 sales selling 60,000 shares for an estimated $1,440,501.
- NEHA KRISHNAMOHAN has made 0 purchases and 2 sales selling 40,504 shares for an estimated $939,493.
- LARRY TODD EDWARDS (See Remarks) has made 0 purchases and 4 sales selling 35,687 shares for an estimated $875,513.
- SUE-JEAN LIN sold 25,272 shares for an estimated $777,955
- HALLEY E GILBERT sold 16,532 shares for an estimated $455,441
- LATHA VAIRAVAN (SVP Chief Financial Officer) has made 0 purchases and 2 sales selling 1,408 shares for an estimated $35,833.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$ARQT Hedge Fund Activity
We have seen 130 institutional investors add shares of $ARQT stock to their portfolio, and 107 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- JENNISON ASSOCIATES LLC removed 5,496,113 shares (-44.9%) from their portfolio in Q4 2025, for an estimated $159,607,121
- POINT72 ASSET MANAGEMENT, L.P. removed 1,485,425 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $28,000,261
- PERPETUAL LTD removed 1,113,976 shares (-55.0%) from their portfolio in Q4 2025, for an estimated $32,349,863
- SUVRETTA CAPITAL MANAGEMENT, LLC removed 1,057,582 shares (-9.2%) from their portfolio in Q3 2025, for an estimated $19,935,420
- VOLORIDGE INVESTMENT MANAGEMENT, LLC added 833,490 shares (+inf%) to their portfolio in Q3 2025, for an estimated $15,711,286
- MILLENNIUM MANAGEMENT LLC removed 760,742 shares (-83.5%) from their portfolio in Q3 2025, for an estimated $14,339,986
- NUVEEN, LLC added 604,777 shares (+79.0%) to their portfolio in Q3 2025, for an estimated $11,400,046
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$ARQT Congressional Stock Trading
Members of Congress have traded $ARQT stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $ARQT stock by members of Congress over the last 6 months:
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. sold up to $15,000 on 12/11.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$ARQT Analyst Ratings
Wall Street analysts have issued reports on $ARQT in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Mizuho issued a "Outperform" rating on 11/28/2025
- Needham issued a "Buy" rating on 10/28/2025
To track analyst ratings and price targets for $ARQT, check out Quiver Quantitative's $ARQT forecast page.
$ARQT Price Targets
Multiple analysts have issued price targets for $ARQT recently. We have seen 3 analysts offer price targets for $ARQT in the last 6 months, with a median target of $31.0.
Here are some recent targets:
- Serge Belanger from Needham set a target price of $31.0 on 01/26/2026
- Uy Ear from Mizuho set a target price of $37.0 on 11/28/2025
- Richard Law from Goldman Sachs set a target price of $29.0 on 10/30/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
